Mitchell Kapoor
Stock Analyst at HC Wainwright & Co.
(4.01)
# 629
Out of 5,182 analysts
336
Total ratings
41.94%
Success rate
15.11%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Mitchell Kapoor
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CRSP CRISPR Therapeutics AG | Maintains: Buy | $65 → $80 | $50.99 | +56.89% | 5 | Aug 7, 2025 | |
| HALO Halozyme Therapeutics | Maintains: Buy | $72 → $75 | $64.49 | +16.30% | 37 | Aug 6, 2025 | |
| IONS Ionis Pharmaceuticals | Maintains: Buy | $50 → $65 | $72.23 | -10.01% | 5 | Jul 31, 2025 | |
| ALMS Alumis | Reiterates: Buy | $14 | $24.75 | -43.43% | 13 | Jul 25, 2025 | |
| KRRO Korro Bio | Reiterates: Buy | $100 | $12.84 | +678.82% | 13 | Jul 24, 2025 | |
| ORKA Oruka Therapeutics | Reiterates: Buy | $45 | $76.39 | -41.09% | 6 | Jul 23, 2025 | |
| LEGN Legend Biotech | Reiterates: Buy | $75 | $23.65 | +217.12% | 39 | Jul 17, 2025 | |
| TYRA Tyra Biosciences | Reiterates: Buy | $30 | $36.92 | -18.74% | 20 | Jul 1, 2025 | |
| SMMT Summit Therapeutics | Reiterates: Buy | $44 | $22.12 | +98.92% | 14 | Jul 1, 2025 | |
| SRPT Sarepta Therapeutics | Downgrades: Sell | $40 → $10 | $20.98 | -52.34% | 16 | Jun 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $1 → $10 | $22.77 | -56.08% | 13 | Jun 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $30 | $13.04 | +130.06% | 4 | Jun 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $125 | $8.13 | +1,437.52% | 17 | Jun 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $15 | $14.42 | +4.02% | 1 | Jun 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $5 | $1.47 | +240.14% | 1 | Jun 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $4 → $5 | $8.99 | -44.38% | 7 | May 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $5 | $4.29 | +16.55% | 10 | May 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $23 → $15 | $5.63 | +166.67% | 8 | May 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $50 → $45 | $27.05 | +66.36% | 15 | May 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $3 | $2.89 | +3.81% | 1 | Apr 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $40 | $7.07 | +465.77% | 17 | Apr 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $8.78 | - | 20 | Apr 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $14 → $7 | $1.49 | +371.38% | 9 | Apr 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $5 → $3 | $5.41 | -44.55% | 6 | Apr 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $5 → $2 | $2.25 | -11.11% | 16 | Apr 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $9 | $0.89 | +911.35% | 15 | Apr 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $15 | $5.34 | +180.90% | 2 | Mar 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $36,160,000 → $13,786,000 | $0.25 | +5,536,546,084.74% | 2 | Sep 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | n/a | $2.30 | - | 4 | Jun 2, 2023 |
CRISPR Therapeutics AG
Aug 7, 2025
Maintains: Buy
Price Target: $65 → $80
Current: $50.99
Upside: +56.89%
Halozyme Therapeutics
Aug 6, 2025
Maintains: Buy
Price Target: $72 → $75
Current: $64.49
Upside: +16.30%
Ionis Pharmaceuticals
Jul 31, 2025
Maintains: Buy
Price Target: $50 → $65
Current: $72.23
Upside: -10.01%
Alumis
Jul 25, 2025
Reiterates: Buy
Price Target: $14
Current: $24.75
Upside: -43.43%
Korro Bio
Jul 24, 2025
Reiterates: Buy
Price Target: $100
Current: $12.84
Upside: +678.82%
Oruka Therapeutics
Jul 23, 2025
Reiterates: Buy
Price Target: $45
Current: $76.39
Upside: -41.09%
Legend Biotech
Jul 17, 2025
Reiterates: Buy
Price Target: $75
Current: $23.65
Upside: +217.12%
Tyra Biosciences
Jul 1, 2025
Reiterates: Buy
Price Target: $30
Current: $36.92
Upside: -18.74%
Summit Therapeutics
Jul 1, 2025
Reiterates: Buy
Price Target: $44
Current: $22.12
Upside: +98.92%
Sarepta Therapeutics
Jun 25, 2025
Downgrades: Sell
Price Target: $40 → $10
Current: $20.98
Upside: -52.34%
Jun 24, 2025
Maintains: Neutral
Price Target: $1 → $10
Current: $22.77
Upside: -56.08%
Jun 16, 2025
Reiterates: Buy
Price Target: $30
Current: $13.04
Upside: +130.06%
Jun 5, 2025
Reiterates: Buy
Price Target: $125
Current: $8.13
Upside: +1,437.52%
Jun 2, 2025
Assumes: Buy
Price Target: $15
Current: $14.42
Upside: +4.02%
Jun 2, 2025
Initiates: Buy
Price Target: $5
Current: $1.47
Upside: +240.14%
May 27, 2025
Upgrades: Buy
Price Target: $4 → $5
Current: $8.99
Upside: -44.38%
May 20, 2025
Reiterates: Buy
Price Target: $5
Current: $4.29
Upside: +16.55%
May 16, 2025
Maintains: Buy
Price Target: $23 → $15
Current: $5.63
Upside: +166.67%
May 13, 2025
Maintains: Buy
Price Target: $50 → $45
Current: $27.05
Upside: +66.36%
Apr 28, 2025
Initiates: Buy
Price Target: $3
Current: $2.89
Upside: +3.81%
Apr 9, 2025
Reiterates: Buy
Price Target: $40
Current: $7.07
Upside: +465.77%
Apr 9, 2025
Downgrades: Neutral
Price Target: n/a
Current: $8.78
Upside: -
Apr 3, 2025
Maintains: Buy
Price Target: $14 → $7
Current: $1.49
Upside: +371.38%
Apr 3, 2025
Maintains: Neutral
Price Target: $5 → $3
Current: $5.41
Upside: -44.55%
Apr 3, 2025
Maintains: Buy
Price Target: $5 → $2
Current: $2.25
Upside: -11.11%
Apr 3, 2025
Reiterates: Buy
Price Target: $9
Current: $0.89
Upside: +911.35%
Mar 24, 2025
Reiterates: Buy
Price Target: $15
Current: $5.34
Upside: +180.90%
Sep 6, 2023
Maintains: Buy
Price Target: $36,160,000 → $13,786,000
Current: $0.25
Upside: +5,536,546,084.74%
Jun 2, 2023
Reiterates: Neutral
Price Target: n/a
Current: $2.30
Upside: -